Ibaraki, Japan

Toshimi Okada



Average Co-Inventor Count = 11.5

ph-index = 6

Forward Citations = 104(Granted Patents)


Location History:

  • Ibaraki, JP (1993 - 2006)
  • Tsuchiura, JP (2007)
  • Tsukuba, JP (2015)

Company Filing History:


Years Active: 1993-2015

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Toshimi Okada: Innovator in Pharmaceutical Chemistry

Introduction

Toshimi Okada is a prominent inventor based in Ibaraki, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of 11 patents to his name, Okada has made remarkable advancements in the field, particularly in the development of novel compounds with therapeutic applications.

Latest Patents

Among his latest patents, Okada has developed a monocyclic pyridine derivative that exhibits FGFR inhibitory activity. This invention provides a novel compound or a pharmaceutically acceptable salt thereof, along with a pharmaceutical composition containing the same. The compound is represented by a specific formula, where various groups and atoms are defined to enhance its efficacy. Additionally, he has worked on the pharmaceutical use of N-carbamoylazole derivatives, which are recognized for their DPPIV inhibiting effects. This invention includes a dipeptidyl peptidase IV inhibiting agent comprising a compound represented by a general formula.

Career Highlights

Throughout his career, Toshimi Okada has been associated with notable companies such as Eisai Company, Limited and Eisai R&D Management Co., Ltd. His work in these organizations has allowed him to focus on innovative research and development in the pharmaceutical sector.

Collaborations

Okada has collaborated with esteemed colleagues, including Hiroshi Yoshino and Hiroyuki Sugumi, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Toshimi Okada's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to impact the development of new therapeutic agents, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…